Stealthy MedyMatch emerged in February with plans to improve emergency room care using cognitive analysis and artificial intelligence. Now, in its first collaboration with a U.S. hospital, the company is developing its first real-time decision-support tool using data from New Jersey-based Capital Health.
Under the agreement, Capital Health will supply Israel-based MedyMatch with anonymized data to help it develop the tool, which will target stroke patients. It will analyze medical images and provide the ER radiologist with information to help him or her determine the course of treatment. It combines "deep vision, advanced cognitive analytics and artificial intelligence" to analyze images and identify anomalies that may be invisible to the human eye. The company plans to partner with several more U.S. hospitals to improve stroke patient outcomes.
"Having access to an archive of anonymized medical imaging data, and understanding the patient outcomes, represents an unprecedented opportunity for the MedyMatch artificial intelligence to self-learn, auto label and tag, hundreds of diseases." said Chief Operating Officer Robert Mehler in a statement.
MedyMatch is helmed by former Philips Imaging CEO Gene Saragnese and is aiming for FDA approval this year. It will also use CT, X-ray, MRI, ultrasound and PET images as part of its R&D efforts to train its suite of applications and deep-learning algorithms.
"MedyMatch's artificial intelligence capability augments physicians' reading ability and provides a second set of eyes on the patient's imaging study. In the area of stroke where time equals brain, it is critical to get a fast, spot on diagnosis," said Dr. Ajay Choudhri, director of Vascular and Interventional Radiology and assistant director of Radiology at Capital Health, in the statement.
- here's the statement